[Skip to Navigation]
Sign In
Views 4,447
Citations 0
Viewpoint
October 18, 2021

The Affordable Care Act Resurrected: Curtailing the Ranks of the Uninsured

Author Affiliations
  • 1Medical Science, Medicine and Biological Sciences, Brown University, Providence, Rhode Island
  • 2Library Planning and Assessment, Brown University Library, Providence, Rhode Island
  • 3Harvard Law School, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard University, Cambridge, Massachusetts
JAMA. 2021;326(18):1797-1798. doi:10.1001/jama.2021.17531

On June 17, 2021, in California v Texas, a majority of the US Supreme Court rejected the latest challenge to the constitutionality of the Affordable Care Act (ACA) on the grounds that the plaintiffs lacked standing to bring their claims.1 This ruling marks the third time that the US Supreme Court rejected a challenge to the constitutionality of the ACA.1 The new lease on life for the ACA creates a window of opportunity for curtailing the ranks of the uninsured. Living up to this imperative will require the executive and legislative branches of the federal government to make the most of the policy options available to them. This Viewpoint reviews the national coverage gap and its potential redress by enhancing federal outreach to the uninsured, rendering permanent the health insurance benefits of the American Rescue Plan Act (ARPA), and establishing a federal health insurance program for low-income adults in states that did not expand their Medicaid programs.

Add or change institution
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×